ECM
GMED icon

Everence Capital Management’s Globus Medical GMED Stock Holding History

Everence Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,644
Closed -$314K – 885
2026
Q1 		$314K Buy
3,644
+1,174
+48% +$105K 0.02% 553
2025
Q4 		$216K Buy
+2,470
New +$187K 0.01% 723
2025
Q1 		– Sell
-2,470
Closed -$204K – 806
2024
Q4 		$204K Buy
+2,470
New +$195K 0.01% 770

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Everence Capital Management's GMED Position: Q2 2026 in Review

Everence Capital Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 3,644 shares — an estimated $314K sold.

Everence Capital Management first reported a position in GMED in Q4 2024 and held it in 3 quarters. The position peaked at $314K in Q1 2026. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Everence Capital Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
  • Everence Capital Management sold 3,644 Globus Medical shares in Q2 2026, an estimated $314K.
  • Everence Capital Management first reported a position in Globus Medical in Q4 2024 and held it in 3 quarters.
  • Everence Capital Management's Globus Medical position peaked at $314K in Q1 2026.
  • 599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.